Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-23

Clinical Trial Update: Erector Spinae Block With Ropivacaine and Dexmedetomidine on Opioid Consumption After Lumar Spine Surgeries [Phase 4]

View source ↗

Summary

Clinical trial update for an opioid consumption study after lumbar spine surgery evaluating erector spinae block with ropivacaine and dexmedetomidine (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Ropivacaine (Ropivacaine)

Snippet

Sponsor: Security Forces Hospital | Conditions: Postoperative Pain | Phase 4 | Status: UNKNOWN